Experto médico comparte tratamientos prometedores y las últimas investigaciones para los cánceres ginecológicos

Medical expert shares promising treatments and latest research for gynecologic cancers

Ovarian cancer – despite medical and surgical advancements – remains the leading cause of death from cancers affecting women's reproductive organs. At the same time, the number of deaths from endometrial cancer is rapidly increasing. 

As part of DocTalks, a monthly virtual speaker series, Christopher Darus, M.D., MS,, medical director, Providence Gynecologic Oncology Program, shares the latest news in gynecologic cancers and explains how new treatments and research are creating hope for patients.

Topics include: 

  • What does the comprehensive care model for gynecologic cancer at Providence entail? 
  • Why are some gynecologic cancers becoming less common while others are increasing? 
  • What promising treatments for gynecologic cancers, including immunotherapy, are being researched at Providence Cancer Institute? 

This virtual education event was presented by Providence Foundations of Oregon and Providence Cancer Institute of Oregon.  

About Dr. Christopher Darus

Dr. Christopher Darus joined Providence Cancer Institute in October 2020 as medical director of Providence Gynecologic Oncology Program. He previously was director of gynecologic cancer research at Maine Medical Center in Portland, Maine.

Dr. Darus graduated from Wright State University School of Medicine in 2000 and completed his residency in obstetrics and gynecology at University of Colorado Health Sciences Center in 2004. Following his residency, he completed a fellowship in gynecologic oncology at the University of Virginia Health System. This rigorous training prepared Dr. Darus to offer advanced surgical and medical treatment techniques to his patients.

Dr. Darus has an acute understanding of the impact of a gynecologic cancer diagnosis and treatment on his patients and their families. He emphasizes the importance of treating the whole patient while utilizing the skills and strengths of the multidisciplinary team of providers at Providence Cancer Institute. His clinical interests include minimally invasive surgery, clinical trials and cancer genomics.

Dr. Darus is an avid cook and enjoys scuba diving and underwater photography. He lives in Portland with his wife and children.

Exceptional gynecologic cancer care

The Providence Gynecologic Oncology Program provides specialized care for women with suspected or known gynecologic malignancies and complex precancerous conditions. We offer care at two locations: Robert W. Franz Cancer Center at Providence Portland Medical Center and Providence St. Vincent Medical Center.

Through the program, patients have access to advanced treatments, such as robotic surgery, immunotherapy, and the latest research and clinical trials. Patients also have the convenience of receiving all their care in a single location. Learn more.

Related news:

Clinical trial aims to help premenopausal women at risk for ovarian cancer

Phase II study of neoadjuvant combination therapy for ovarian cancer

Gynecologic oncology care now available at Providence Cancer Institute

 

11/23/2022
Providence Cancer Institute to hold two virtual events on the benefits of integrative medicine for patients.
11/7/2022
Providence Cancer Institute one of only a few sites worldwide offering two new clinical trials for solid tumors and lung cancer.
10/6/2022
Providence Cancer Institute is currently recruiting participants for three new clinical studies offered for people with HER2-neu negative breast cancer.
10/19/2022
Leading lung cancer professionals to gather in November for premier oncology summit.
Powered by Translations.com GlobalLink OneLink SoftwarePowered By OneLink